发明公开
- 专利标题： NANT CANCER VACCINE
-
申请号： EP22182406.3申请日： 2017-06-30
-
公开(公告)号： EP4101447A1公开(公告)日： 2022-12-14
- 发明人: SOON-SHIONG, Patrick , NIAZI, Kayvan , RABIZADEH, Shahrooz
- 申请人： Nant Holdings IP, LLC , NantCell, Inc.
- 申请人地址： US Los Angeles, CA 90025 11755 Wilshire Boulevard Suite 2000; US Culver City, CA 90232 9920 Jefferson Boulevard
- 代理机构： Tomkins & Co
- 优先权： US201762474034 P 20170320
- 主分类号： A61K31/337
- IPC分类号： A61K31/337
摘要：
Cancer is treated using coordinated treatment regimens that uses various compounds and compositions that drive a tumor from the escape phase of cancer immunoediting to the elimination and equilibrium phase of cancer immunoediting.
信息查询
